Home » Industry News and Resources
Friday, November 20, 2009 09:07 AM
Thursday, November 19, 2009 03:35 PM
Less than a month after announcing its acquisition of China-based contract research organization (CRO) Excel PharmaStudies and plans to dominate the Asia-Pacific region,PPD, the Wilmington, N.C.-based global CRO has signed an agreement to acquire BioDuro LLC, a drug discovery outsourcing company. The acquisition of the 660-employee company will expand PPD's drug development capabilities in China.
Founded in 2005, BioDuro operates a 110,000-square-foot laboratory in Beijing. Most of its employees are based in China, where it provides scientific expertise in medicinal chemistry, biology, pharmacology, drug metabolism, pharmacokinetic and safety services. The company offers integrated scientific resources and services to synthesize novel compounds and optimize those compounds to generate drug development candidates.
More... »
Thursday, November 19, 2009 08:28 AM
Charging that the Carle Foundation Hospital and Carle Clinic failed to protect cancer patients in their clinical trials, Suzanne Stratton, Ph.D, the former vice president for research at the Carle Foundation Hospital in Urbana, Ill., filed a whistleblower lawsuit in federal court against the hospital’s chief executive officer, the Carle Clinic Association, Kendrith Rowland, M.D., a lead physician at the Carle Clinic, and Bruce Wellman, M.D., the Carle Clinic CEO.
Stratton alleges she was fired in retaliation on Nov. 18, 2008 for her repeated warnings that the Carle Foundation Hospital and the Carle Clinic had violated federal regulations intended to protect cancer patients enrolled as subjects in clinical trials. She was hired in early 2007 to help oversee cancer trials there.
More... »
Wednesday, November 18, 2009 08:18 AM
Whippany, N.J.-based ISI, a provider of software and services for the life sciences industry, has acquired Apyx in an effort to boost ISI’s services business.
The acquisition helps ISI strengthen its capabilities to offer clients a mix of process, technology, data and operational services in a complex regulatory submission environment. ISI’s professional services business already saw a 26% increase in sales from 2007 to 2008.
More... »
Tuesday, November 17, 2009 10:27 AM
Encorium Group, a CRO, reported third quarter revenue decreased 18% to $4.5 million but its loss from continuing operations narrowed to $643,389 or $(0.04) per diluted share for the third quarter of 2009, from a net loss of $2.4 million, or $(0.12) per diluted share, in the third quarter of 2008.
In July, the company sold substantially all of the assets of its U.S. business to Pierrel Research USA. Due to this sale, for the three and nine months ended Sept. 30, 2009 and 2008, the results of the U.S. business have been presented as discontinued operations in the company's consolidated financial statements.
More... »
Tuesday, November 17, 2009 07:30 AM
Datatrak International, a technology and services company focused on eClinical solutions, reported third quarter revenues fell 34% to $1.55 million compared with the prior year quarter but its net loss narrowed.
Compared to the prior year third quarter, combined direct cost and selling, general and administrative expenses decreased approximately $1.8 million, or nearly in half.
More... »
Monday, November 16, 2009 06:55 AM
New York-based Medidata Solutions, a provider of hosted clinical development solutions, reported third quarter profits soared on revenues that jumped 27% compared with the year ago quarter.
Non-GAAP net income for the third quarter of 2009 was $3.5 million, or $0.15 per diluted share, compared with a loss of $2.1 million, or $0.32 per diluted share, in the third quarter of 2008.
More... »
Friday, November 13, 2009 07:50 AM
Parexel has established The Expert Office, which provides a single point of contact for clients to more quickly access the company’s worldwide clinical research expertise.
The Expert Office aligns the company's leading medical, therapeutic area, regulatory, and clinical operations experts with their counterparts at biopharmaceutical companies. It is designed to deliver a new level of strategic partnering based on program design expertise, operational excellence, and project leadership.
More... »
Thursday, November 12, 2009 07:45 AM
ICON has signed an extension to its strategic agreement with Eli Lilly and Company to manage the company’s clinical data management outside the U.S. This extension means that ICON will now also manage Lilly’s needs in Japan in addition to those in Europe, Canada, Latin America, Australia and Asia, which was originally agreed to in November 2008.
Lilly also selected ICON to manage clinical trial site set up and monitoring in Europe for Lilly-managed studies in June 2009.
More... »
Wednesday, November 11, 2009 06:56 AM
Premier Research Group, an international pharmaceutical and medical device services company, is expanding its functional sourcing resources to Eastern Europe.
Ajay Sadhwani, vice president of Premier Research’s Functional Sourcing group stated, “These experienced professionals are based in Premier Research’s existing offices in Bulgaria and Slovakia offering a strong presence and capacity to provide low-cost data processing services. This further extends the reach of our group and enhances the flexibility we can offer clients.”
More... »
